Search research articles
Contact Us
Filters
Showing results (811-820 of 874) with videos related to
Page
of 88
Sort By:
Cancer Medicine
|
December 23, 2023
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, et al.
Chemical Communications (Cambridge, England)
|
May 30, 2018
Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodies
Sachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Chemical Communications (Cambridge, England)
|
July 3, 2018
Correction: Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodies
Sachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 8, 2017
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
Wen-Chi Yang, Furen Xiao, Jin-Yuan Shih, et al.
Cell Metabolism
|
September 3, 2020
Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice
Azar Asadi Shahmirzadi, Daniel Edgar, Chen-Yu Liao, et al.
Bioorganic Chemistry
|
April 6, 2021
Development of biotinylated and magnetic bead-immobilized enzymes for efficient glyco-engineering and isolation of antibodies
Hong-Yang Chuang, Chiu-Chen Huang, Ting-Chun Hung, et al.
BMC Geriatrics
|
November 28, 2020
HOme-based Longitudinal Investigation of the multidiSciplinary Team Integrated Care (HOLISTIC): protocol of a prospective nationwide cohort study
Jung-Yu Liao, Ping-Jen Chen, Yu-Lin Wu, et al.
The Lancet. Respiratory Medicine
|
December 19, 2017
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
Chia-Chi Lin, Jin-Yuan Shih, Chong-Jen Yu, et al.
Frontiers in Immunology
|
October 7, 2022
Disease predisposition of human leukocyte antigen class II genes influences the gut microbiota composition in patients with primary biliary cholangitis
Chun-Yang Huang, Hai-Ping Zhang, Wei-Jia Han, et al.
Clinical and Translational Medicine
|
December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
Shang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.
Page
of 88
Search research articles
Search
Showing results (811-820 of 874) with videos related to
Sort By:
Page
of 88
Cancer Medicine
|
December 23, 2023
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, et al.
Chemical Communications (Cambridge, England)
|
May 30, 2018
Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodies
Sachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Chemical Communications (Cambridge, England)
|
July 3, 2018
Correction: Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodies
Sachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 8, 2017
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
Wen-Chi Yang, Furen Xiao, Jin-Yuan Shih, et al.
Cell Metabolism
|
September 3, 2020
Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice
Azar Asadi Shahmirzadi, Daniel Edgar, Chen-Yu Liao, et al.
Bioorganic Chemistry
|
April 6, 2021
Development of biotinylated and magnetic bead-immobilized enzymes for efficient glyco-engineering and isolation of antibodies
Hong-Yang Chuang, Chiu-Chen Huang, Ting-Chun Hung, et al.
BMC Geriatrics
|
November 28, 2020
HOme-based Longitudinal Investigation of the multidiSciplinary Team Integrated Care (HOLISTIC): protocol of a prospective nationwide cohort study
Jung-Yu Liao, Ping-Jen Chen, Yu-Lin Wu, et al.
The Lancet. Respiratory Medicine
|
December 19, 2017
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
Chia-Chi Lin, Jin-Yuan Shih, Chong-Jen Yu, et al.
Frontiers in Immunology
|
October 7, 2022
Disease predisposition of human leukocyte antigen class II genes influences the gut microbiota composition in patients with primary biliary cholangitis
Chun-Yang Huang, Hai-Ping Zhang, Wei-Jia Han, et al.
Clinical and Translational Medicine
|
December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
Shang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.
Page
of 88